malignant adenoma

恶性腺瘤

医学



双语例句

  1. Objective: The aim is to study clinical feature, diagnosis, therapy and prognosis of malignant pleomorphic adenoma ( MPA) of tongue base with bilateral cervical lymph node metastasis.
    目的:研究舌根恶性多形性腺瘤(MPA)双侧颈淋巴结内癌转移的临床表现、诊断、治疗及预后。
  2. Prognostic analysis of 138 patients with pN~+ tougue squamous cell carcinoma Malignant pleomorphic adenoma of tongue base with bilateral cervical lymph node metastases
    颈部淋巴结转移舌体鳞状细胞癌138例的预后分析
  3. The Mechanism of Malignant Transformation of Pleomorphic Adenoma and the Retrospective Analyse of the Data
    多形性腺瘤的恶变原因分析与文献回顾
  4. The tumor could transform to malignancy as malignant pleomorphic adenoma ( MPA), if the preexisting PA remains for long time or after multiple recurrences.
    涎腺多形性腺瘤是最常见的涎腺上皮性肿瘤,多次复发或病程长者可恶变为恶性多形性腺瘤。
  5. Ultrasound Study of Parotid benign and malignant Pleomorphic adenoma
    腮腺良性和恶性多形性腺瘤的超声研究
  6. Non-invasive malignant pleomorphic adenoma of the submandibular gland: Report of one lase
    下颌下腺非侵袭性恶性多形性腺瘤1例报告
  7. FTIR Spectroscopic Investigation of Normal and Malignant Pleomorphic Adenoma
    恶性多形性腺瘤及其周围正常组织的FTIR光谱研究
  8. Methods Samples were divided into normal group, pleomorphic adenoma ( PA) and malignant pleomorphic adenoma group ( MPA).
    方法实验分为正常组、多形性腺瘤组(PA)和恶性多形性腺瘤组(MPA)。
  9. Purpose To analyze the clinicopathologic features of salivary malignant pleomorphic adenoma.
    目的分析涎腺恶性多形性腺瘤(malignantpleomorphicadenoma,MPA)的临床病理特征。
  10. Objective To investigate the causes of recurrence and malignant change of pleomorphic adenoma ( benign mixed tumour) of lacrimal gland.
    目的探讨泪腺良性多形性腺瘤术后易复发和恶性变的原因。
  11. Malignant Changes of Colon Adenoma: X-ray Signs
    结肠腺瘤恶变的X线征象分析
  12. In the pathological type of tumor in pharynx, the squamous cell carcinoma, malignant lymphoma, fibroangioma and pleomorphic adenoma were the main tumor type ( 92 3%), and majority of pathological type of pharynx tumor was happened in nasopharynx.
    咽部肿瘤的病理类型中鳞状细胞癌、恶性淋巴瘤、纤维血管瘤和多形性腺瘤等为主要的肿瘤类型,合计占923%,并且咽部肿瘤的大部分发生在鼻咽部。
  13. Significant risk factors of malignant transformation in colorectal adenoma
    大肠腺瘤恶变的主要危险因素
  14. Clinicopathological study on 230 cases of benign malignant pleomorphic adenoma from salivary gland
    230例涎腺良、恶性多形性腺瘤临床病理研究
  15. Adenomas and 40 carcinomas contained more than two protein expressions and their co-expression was associated with the malignant potential of adenoma and the prognosis of carcinoma.
    9例腺瘤,40例腺癌存在两种以上蛋白表达,共同表达与腺瘤恶性倾向及腺癌预后有关。
  16. Clinical pathological study of 108 cases with malignant pleomorphic adenoma of salivary gland
    涎腺多形性腺瘤恶变108例临床病理分析
  17. Association of HPV with malignant transformed colorectal adenoma
    大肠腺瘤恶变与HPV感染的关系
  18. Histological and Histochemical Observation of Cervical Malignant Adenoma s
    宫颈恶性腺瘤组织学和组织化学研究
  19. The analysis of ras gene expression and the prognosis of malignant pleomorphic adenoma
    ras癌基因表达与恶性多形性腺瘤预后的相关分析
  20. Expression of CEA Oncogene ras P21 and PCNA in the Process of Malignant Transformation of Colon Adenoma
    CEA、rasp21和PCNA在大肠腺瘤癌变中的表达
  21. Histopathologic Types of Malignant Pleomorphic Adenoma of Salivary Glands
    涎腺恶性多形性腺瘤的病理类型
  22. The malignant change rate of adenoma was as high as 26. 9%.
    腺瘤癌变率达26.9%。
  23. With the advantages of histological and cell proliferation analysis, PCNA, not only can provide support for the diagnosis of malignant pleomorphic adenoma, but also can provide basis for clinical treatment and prognosis assessment.
    PCNA具有组织学和细胞增殖同时分析的优点,不仅为恶性多形性腺瘤的诊断提供支持,同时也为临床治疗和预后评估提供依据。
  24. The excessive expression of PCNA protein maybe related with the occurrence and development of benign and malignant pleomorphic adenoma. 3.
    PCNA蛋白的过度表达可能与良、恶性多形性腺瘤发生发展有关。
  25. The high expression of PCNA in malignant pleomorphic adenoma points out that its proliferation activity is higher than that of benign pleomorphic adenoma and normal parotid tissue, and the proliferation activity of benign and malignant pleomorphic adenoma is significantly higher than that of normal parotid tissue.
    恶性多形性腺瘤PCNA高表达提示恶性多形腺瘤的增殖活性高于良性多形性腺瘤及正常腮腺组织;良、恶多形性腺瘤增殖活性显著高于腮腺正常组织。